Childhood Obesity and Overweight in Ghana: A Systematic Review and Meta-Analysis

Prince Kwaku Akowuah1, Emmanuel Kobia-Acquah1

  • 1Department of Optometry and Visual Science, Kwame Nkrumah University of Science and Technology, Private Mail Bag, University Post Office, Kumasi, Ghana.

Insights

Childhood obesity and overweight affect approximately 19% of children in Ghana. This systematic review highlights a significant public health concern, particularly in rural areas, necessitating urgent interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatrics

Background:

  • Childhood obesity and overweight are escalating global public health issues.
  • Ghana faces a growing challenge with pediatric overweight and obesity rates.
  • Understanding the prevalence is crucial for developing targeted health strategies.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of childhood obesity and overweight in Ghana.
  • To provide an updated estimate of the burden of pediatric obesity in the country.
  • To identify potential demographic or geographic disparities in prevalence.

Main Methods:

  • Systematic review and meta-analysis of studies published between 2001 and 2019.
  • Searched multiple databases including PubMed, Scopus, and WHO databases.
  • Pooled data from 16 studies (n=29,160) using random-effects modeling.

Main Results:

  • An overall prevalence of 19% for childhood obesity and overweight was estimated in Ghana.
  • Specific prevalence rates: 8.6% for obesity and 10.7% for overweight.
  • Significantly higher obesity prevalence was found in rural settings (17.4%) compared to urban settings (8.9%).

Conclusions:

  • The estimated 19% prevalence of childhood obesity and overweight in Ghana is a significant public health concern.
  • Higher prevalence in rural areas warrants further investigation into contributing factors.
  • Proactive public health measures are essential to address this growing issue and protect future generations.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
162
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
116
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
181
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
369